Extrarenal effects of diuretic agents.
D000141:Acidosis, Renal Tubular / Q000139:chemically induced; D000273:Adipose Tissue / Q000378:metabolism; D000471:Alkalosis / Q000139:chemically induced; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001810:Blood Volume; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects*; D004912:Erythrocytes / Q000378:metabolism; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000096:biosynthesis; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D008564:Membrane Potentials / Q000187:drug effects; D011188:Potassium / Q000652:urine; D011719:Pyrazines / Q000009:adverse effects; D012964:Sodium / Q000378:metabolism; D013148:Spironolactone / Q000009:adverse effects; D014223:Triamterene / Q000494:pharmacology
D000959:Antihypertensive Agents; D004232:Diuretics; D011719:Pyrazines; D013148:Spironolactone; D005665:Furosemide; D006003:Glycogen; D012964:Sodium; D005947:Glucose; D004976:Ethacrynic Acid; D011188:Potassium; D014223:Triamterene